Antibodies

Antibodies

Alphageneron is researching checkpoint inhibitor and Antibody Drug Conjugate (ADC) antibodies that can assist T-cells or NK-Cells to engage the tumor cell, for better cytotoxic killing by the immune cells.

We are developing an ADC antibody that targets HSP-70, a tumor-specific¬†marker expressed on a majority of cancers. The product can be used in a “magic bullet” to deliver a cytotoxic conjugate directly, to tumor cells.¬†